# K233259: Xerosyn

- Pathway: 510(k) (Traditional)
- Applicant: Xerothera, Inc.
- Decided: Jun 21, 2024 after 266 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 11 generations back to K960978 (1996). 43 ancestors in all.
No later device cites it as a predicate yet.
0 of 44 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K192363: Altapore, Baxter Healthcare Corporation (2020) Summary page 4.

## Indications for use
XeroSyn bone void filler is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). XeroSyn is used with autograft as a bone graft extender in the extremities and pelvis. These osseous defects may be surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. XeroSyn resorbs and is replaced with bone during the healing process.

Source page: https://510kreport.com/device/K233259
Methodology: https://510kreport.com/methodology